Skip to main content

Celmatix Wins $4.5M From New York State to Expand NYC Headquarters

NEW YORK (GenomeWeb) – Women's health company Celmatix has received $4.5 million from the Empire State Development's New York City Regional Economic Development Council (REDC) to expand its headquarters in Manhattan, the company said today.

The award is one of 121 for projects in New York City this year, totaling $64.8 million. Overall, the REDC program awarded more than $755 million in funding to different regions of New York state in 2017.

Celmatix, founded in 2009, currently offers two products: Polaris, a web-based data analytics platform for patient management and counseling, and Fertilome, a genetic test to assess the risk for certain reproductive conditions.

Last month, the company received approval from the New York State Department of Health for the Fertilome test.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.